MARÍA ARANZAZU
AIS LARISGOITIA
Profesora asociada de Ciencias de la Salud
Publicaciones (16) Publicaciones de MARÍA ARANZAZU AIS LARISGOITIA
2024
-
Experience of patients with immune-mediated inflammatory diseases seen in a multidisciplinary integrated care unit
Journal of Healthcare Quality Research, Vol. 39, Núm. 5, pp. 283-290
-
Perceived quality of life by patients with immune-mediated inflammatory diseases treated with biological therapies. SACVINFA study
Farmacia Hospitalaria
2023
-
Medicamentos inmunosupresores y biológicos en el embarazo, la lactancia y la fertilidad en enfermedades inmunomediadas
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 47, Núm. 1, pp. 39-49
2022
-
Design and implementation of a mobile app for the pharmacotherapeutic follow-up of patients diagnosed with immune-mediated inflammatory diseases: eMidCare
Frontiers in Immunology, Vol. 13
-
Evaluation of the hospital care quality perceived by patients with immune-mediated inflammatory diseases from the pharmacy service. SACVINFA study
Journal of Clinical Pharmacy and Therapeutics, Vol. 47, Núm. 12, pp. 2020-2029
-
Implementation and evaluation of a home pharmaceutical care model through Telepharmacy
Farmacia Hospitalaria, Vol. 46, pp. 36-46
-
Information and Communication Technologies in Patients With Immune-Mediated Inflammatory Diseases: Cross-sectional Survey
Journal of medical Internet research, Vol. 24, Núm. 9, pp. e37445
-
The Characteristics and Functionalities of Mobile Apps Aimed at Patients Diagnosed With Immune-Mediated Inflammatory Diseases: Systematic App Search
Journal of Medical Internet Research, Vol. 24, Núm. 3
2016
-
Antiinfecciosos vía general
Medimecum 2016: guía de terapia farmacológica ([Madrid] : Springer), pp. 559-728
-
Antiparasitarios
Medimecum 2016: guía de terapia farmacológica ([Madrid] : Springer), pp. 1073-1091
2013
-
Equipotent doses of pegylated epoetin β (CERA) for the treatment of outcome patients with anemia secondary to chronic kidney disease in clinical practice
Atencion Farmaceutica, Vol. 15, Núm. 1, pp. 55-58
-
Information leaflets for patients with hepatitis C receiving treatment with triple therapy
European Journal of Hospital Pharmacy, Vol. 20, Núm. 1, pp. 13-19
-
Nuevos tratamientos para la esclerosis múltiple
Medicina Clinica, Vol. 140, Núm. 2, pp. 76-82
-
Permanencia del tratamiento antirretroviral de última generación en la práctica clínica diaria
Farmacia Hospitalaria, Vol. 37, Núm. 2, pp. 151-155
2011
-
Evolution of adherence to antiretroviral treatment in a spanish hospital during 2001, 2005 and 2008
Latin American Journal of Pharmacy, Vol. 30, Núm. 6, pp. 1173-1178
-
Indicación de uso de los antirretrovirales de última generación en la práctica clínica actual
Farmacia Hospitalaria, Vol. 35, Núm. 1, pp. 14-22